Efficacy of the DAC inhibitor LBH589 in both rituximab-sensitive and rituximab-resistant lymphomas and effect on the antitumor activity of chemotherapy agents, monoclonal antibodies, and bortezomib
| Autor: | I Maraj, F J Hernandez-Ilizaliturri, M Chisti, M S Czuczman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| DOI: | 10.13140/2.1.2195.5366 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|